First-Trimester Soluble sFlt-1 for the Prediction of Preterm Preeclampsia.

J Obstet Gynaecol Can

Department of Obstetrics and Gynecology, Faculty of Medicine, Université Laval, Quebec City, Canada; Centre de recherche du CHU de Québec - Université Laval, Quebec City, Canada. Electronic address:

Published: December 2024

While soluble fms-like tyrosine kinase 1 (sFlt-1) is used to predict preeclampsia (PE) and its severity in late pregnancy, we aimed to clarify its role in early pregnancy. Using prospective cohorts, we estimated the association between sFlt-1, adjusted for gestational age, and preterm PE. sFlt-1 was significantly decreased in the first trimester, mostly before the 13th week, and significantly increased in the third trimester in those who developed preterm PE and particularly early-onset PE. We hypothesize that sFlt-1 evolves from low to high values in early to late pregnancy among women with preterm and early-onset PE.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jogc.2024.102753DOI Listing

Publication Analysis

Top Keywords

late pregnancy
8
preterm early-onset
8
sflt-1
5
first-trimester soluble
4
soluble sflt-1
4
sflt-1 prediction
4
preterm
4
prediction preterm
4
preterm preeclampsia
4
preeclampsia soluble
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!